Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimizing the Ocular Surface With Systane COMPLETE Pre- and Post-operatively in Patients With Dry Eye Planning for Cataract Surgery: An Extension Study
NCT06886373Phase 4Recruiting
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2025
- Primary completion
- Dec 2027
- Modality
- Nanoparticles, Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, open-label trial of propylene glycol-hydroxypropyl guar nanoemulsion in dry eye syndrome (DED) (2 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Change of the keratometry data. Started Mar 2025; status: recruiting.
02
Drugs
propylene glycol-hydroxypropyl guar nanoemulsion
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT06886373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06886373.